China’s Ministry of Commerce has launched an anti-dumping investigation into imported medical CT tubes from the U.S. and India and has also ...

FPT and GE HealthCare (GEHC) announced a strategic cooperation agreement, expanding their commercial alliance to advance product strategy and ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

GE HealthCare has raised the curtain on a new CT system with features designed specifically for addressing cardiovascular ...

We recently published a list of Top 9 AI Ratings and News Updates on Wall Street’s Radar. In this article, we are going to ...

GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.

GE HealthCare is rolling out a new computed tomography (CT) system to support practitioners in diagnosing complex CAD cases.

Introduced at ACC.25, the Revolution Vibe CT system includes Unlimited One-Beat Cardiac imaging and combines with GE HealthCare’s ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and Effortless ...

(Chen and Palmer, 3/27) GE HealthCare announced Thursday the commercial launch of Flyrcado, its PET imaging agent that assesses blood flow to the heart muscle, in select U.S. markets. The Centers for ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a provider of healthcare solutions, new-age medical technology, cloud-first AI-enabled solutions, and data analytics services worldwide. On March ...

The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.